Healthcare provider profile · identity verified

Yanjin Yang

Internal Medicine · BROOKLYN, NY · NPI 1003155730

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	946	227
Losartan Potassium	Losartan Potassium	618	158
Amlodipine Besylate	Amlodipine Besylate	497	141
Metoprolol Succinate	Metoprolol Succinate	351	84
Gabapentin	Gabapentin	339	91
Rosuvastatin Calcium	Rosuvastatin Calcium	309	69
Tamsulosin Hcl	Tamsulosin Hcl	261	63
Metformin Hcl	Metformin Hcl	227	56
Levothyroxine Sodium	Levothyroxine Sodium	222	50
Vascepa	Icosapent Ethyl	221	54
Ammonium Lactate	Ammonium Lactate	216	84
Fluticasone Propionate	Fluticasone Propionate	193	68
Omeprazole	Omeprazole	190	54
Vitamin D2	Ergocalciferol (Vitamin D2)	182	72
Jardiance	Empagliflozin	178	38
Albuterol Sulfate Hfa	Albuterol Sulfate	173	62
Clopidogrel	Clopidogrel Bisulfate	153	35
Carvedilol	Carvedilol	147	40
Pantoprazole Sodium	Pantoprazole Sodium	142	53
Glipizide Er	Glipizide	141	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	141	35
Montelukast Sodium	Montelukast Sodium	138	28
Finasteride	Finasteride	137	33
Olmesartan Medoxomil	Olmesartan Medoxomil	131	34
Alcohol Prep Pads	Alcohol Antiseptic Pads	129	30
Raloxifene Hcl	Raloxifene Hcl	128	28
Simvastatin	Simvastatin	126	30
Ezetimibe	Ezetimibe	120	36
Pravastatin Sodium	Pravastatin Sodium	114	28
Allopurinol	Allopurinol	112	29
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	108	31
Furosemide	Furosemide	103	34
Alendronate Sodium	Alendronate Sodium	102	24
Nifedipine Er	Nifedipine	96	19
Tradjenta	Linagliptin	94	22
Eliquis	Apixaban	92	27
Hydrochlorothiazide	Hydrochlorothiazide	90	29
Lisinopril	Lisinopril	90	21
Mometasone Furoate	Mometasone Furoate	90	33
Esomeprazole Magnesium	Esomeprazole Magnesium	89	19
Trazodone Hcl	Trazodone Hcl	86	28
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	82	20
Atenolol	Atenolol	79	17
Mirtazapine	Mirtazapine	77	18
Januvia	Sitagliptin Phosphate	74	19
Donepezil Hcl	Donepezil Hcl	72	18
Famotidine	Famotidine	69	26
Bepotastine Besilate	Bepotastine Besilate	62	18
Bisoprolol Fumarate	Bisoprolol Fumarate	60	20
Azelastine Hcl	Azelastine Hcl	58	15
Meclizine Hcl	Meclizine Hcl	57	30
Breo Ellipta	Fluticasone/Vilanterol	54	suppressed
Glimepiride	Glimepiride	51	14
Chlorhexidine Gluconate	Chlorhexidine Gluconate	50	19
Janumet	Sitagliptin Phos/Metformin Hcl	50	11
Janumet Xr	Sitagliptin Phos/Metformin Hcl	50	12
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	50	12
Triamcinolone Acetonide	Triamcinolone Acetonide	50	24
Celecoxib	Celecoxib	49	34
Lidocaine	Lidocaine	44	16
Metformin Hcl Er	Metformin Hcl	44	19
Dutasteride	Dutasteride	43	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	43	suppressed
Clobetasol Emollient	Clobetasol Propionate/Emoll	42	17
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	41	suppressed
Labetalol Hcl	Labetalol Hcl	40	13
Trulicity	Dulaglutide	40	suppressed
Ozempic	Semaglutide	39	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	38	38
Nebivolol Hcl	Nebivolol Hcl	38	11
Clobetasol Propionate	Clobetasol Propionate	37	17
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Valsartan	Valsartan	36	suppressed
Diclofenac Sodium	Diclofenac Sodium	34	25
Hydrocortisone	Hydrocortisone	33	14
Azithromycin	Azithromycin	32	31
Ciclopirox	Ciclopirox	32	suppressed
Mupirocin	Mupirocin	32	22
Prolia	Denosumab	32	20
Single Use Swab	Alcohol Antiseptic Pads	32	12
Diclofenac Epolamine	Diclofenac Epolamine	30	13
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Enalapril Maleate	Enalapril Maleate	29	suppressed
Glipizide	Glipizide	29	13
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	28	suppressed
Icosapent Ethyl	Icosapent Ethyl	28	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Repatha Sureclick	Evolocumab	27	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	25	25
Chlorthalidone	Chlorthalidone	25	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	25	suppressed
Incruse Ellipta	Umeclidinium Bromide	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Methimazole	Methimazole	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	21
Farxiga	Dapagliflozin Propanediol	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Vemlidy	Tenofovir Alafenamide	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Prednisone	Prednisone	23	20
Telmisartan	Telmisartan	22	suppressed
Torsemide	Torsemide	22	suppressed
Potassium Chloride	Potassium Chloride	21	suppressed
Dexlansoprazole Dr	Dexlansoprazole	20	suppressed
Fenofibrate	Fenofibrate,micronized	20	suppressed
Proctozone-Hc	Hydrocortisone	20	suppressed
Tenofovir Disoproxil Fumarate	Tenofovir Disoproxil Fumarate	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	11
Fenofibrate	Fenofibrate	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	13
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	17	15
Clonazepam	Clonazepam	17	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	16	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	15	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Valacyclovir	Valacyclovir Hcl	14	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Procto-Med Hc	Hydrocortisone	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Nystatin	Nystatin	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Levofloxacin	Levofloxacin	11	11
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error